Maraviroc
8 NDCs across 4 manufacturers|6 Generic,2 Brand
Maraviroc is used to treat HIV infections, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Aug 6, 2007, and the first generic was approved Feb 7, 2022. FDA's Orange Book lists 8 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $23 million on Maraviroc across 17,000 claims for 2,042 beneficiaries.
Maraviroc is available as 8 NDCs from 4 manufacturers (6 generic, 2 brand), with NADAC prices from $6.34 to $28.13 per EA — the most expensive product costs about 4.4× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
8
6G / 2B
Manufacturers
4
competing in market
Price Spread
$6.34 – $28.13
per EA
7d Activity
avg +0.8% WoW · of 8 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
ViiV Healthcare Company manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
CCR5 Co-receptor Antagonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
4 manufacturers producing MARAVIROC
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
SELZENTRY 300 MG TABLET | $28.1311 per EA | — |
SELZENTRY 150 MG TABLET | $28.0158 per EA | — |
MARAVIROC 150 MG TABLET | $9.1496 per EA | — |
MARAVIROC 150 MG TABLET | $9.1496 per EA | — |
MARAVIROC 150 MG TABLET | $9.1496 per EA | — |
MARAVIROC 300 MG TABLET | $6.3391 per EA | +0.82% |
MARAVIROC 300 MG TABLET | $6.3391 per EA | +0.82% |
MARAVIROC 300 MG TABLET | $6.3391 per EA | +0.82% |
Frequently Asked Questions
What is Maraviroc used to treat?
Maraviroc is used to treat HIV infections, per the National Library of Medicine's MED-RT classification.
When did Maraviroc become available as a generic?
FDA approved the first generic Maraviroc (ANDA) on Feb 7, 2022. The Orange Book currently lists 8 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Maraviroc?
In 2024, Medicare Part D spent $23 million on Maraviroc across 17,000 claims for 2,042 beneficiaries.
How many Maraviroc products are on the market?
The Maraviroc drug market contains 8 NDCs from 4 manufacturers — 6 generic and 2 brand products.
What is the price range for Maraviroc?
NADAC reference prices for Maraviroc range from $6.3391 to $28.1311 per EA — the most expensive product costs about 4.4× the cheapest.
Is generic Maraviroc cheaper than brand?
The average generic NADAC for Maraviroc is $7.7444 per EA, versus $28.0735 for brand-labeled products — brand versions average about 3.6× the generic price.
Which manufacturers make Maraviroc?
4 manufacturers list Maraviroc in NADAC. Ranked by number of NDCs, the largest are ViiV Healthcare Company (2), Zydus Pharmaceuticals (USA) Inc. (2), Camber Pharmaceuticals Inc. (2), i3 Pharmaceuticals, LLC (2).
How has the price of Maraviroc changed recently?
Over the past 7 days, 3 Maraviroc NDCs rose and 0 fell, with a market-wide average change of +0.8%.